Enovis™ CEO Matt Trerotola Featured in MassDevice

April 2, 2024

What’s next for Enovis? As a growing global medtech leader, we have a bright future ahead of us. CEO Matt recently sat down with Mass Device editor-in-chief Chris Newmarker to discuss that very question and talk about the great momentum we’re building in 2024 and beyond.

Check out this in-depth article highlighting how we are leading medtech innovation. Read the full story here.